NOVONESIS B UNSP/ADR by NOVONESIS A S Financials - Benzinga

NOVONESIS B UNSP/ADR by NOVONESIS A S

NVZMYOTCPK

Trade with Public

Trade with Public

$70.09

-0.42-0.6%

At close: Aug 21, 5:00 PM EST

Earnings: H1 2026 Earnings were released on Thu Aug 20th, before the market open

Conference Call: The most recent conference call started at 3:00 AM, 2 days ago

Click to view the webcast

Overview News Earnings ForecastFinancialsSentiment Ownership Compare

NOVONESIS B UNSP/ADR by NOVONESIS A S Financials

NOVONESIS B UNSP/ADR by NOVONESIS A S (NVZMY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Novozymes H1 Adj. EPS $1.27 Beats $0.60 Estimate, Sales $2.608B Beat $1.250B Estimate

Novozymes (OTC:NVZMY) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $0.60 by 111.67 percent. This is a 44.32 percent increase over earnings of $0.88 per share from the same

Benzinga Newsdesk

PRO
Novozymes FY Adj. EPS $1.73 Up From $1.39 YoY, Sales $4.158B Miss $4.900B Estimate

Novozymes (OTC:NVZMY) reported quarterly earnings of $1.73 per share. This is a 24.46 percent increase over earnings of $1.39 per share from the same period last year. The company reported quarterly sales of $4.158

Benzinga Newsdesk

PRO
Novozymes H1 Adj. EPS $0.88 Up From $0.69 YoY, Sales $2.376B Up From $2.102B YoY

Novozymes (OTC:NVZMY) reported quarterly earnings of $0.88 per share. This is a 27.54 percent increase over earnings of $0.69 per share from the same period last year. The company reported $2.376 billion in sales this

Benzinga Newsdesk

Recap: Novozymes Q4 Earnings

Benzinga Insights

Novozymes Earnings Preview

Benzinga Insights

Novozymes's Earnings: A Preview

Benzinga Insights